E[ukaryotic]{.smallcaps} cells are able to polarize their growth in response to both external and internal signals. Polarization to external signals plays a crucial role in development and tissue formation. During yeast mating, cells of opposite mating type secrete peptide pheromones and respond to pheromone from their mating partner (for review see [@B68]; [@B18]; [@B38]). Mating pheromone binds to specific G-protein--coupled receptors on cells of opposite mating type ([@B9]; [@B11]). Receptor activation results in cell cycle arrest, transcriptional activation, morphological changes, and polarized growth towards a partner cell ([@B68]; [@B18]; [@B38]).

Cells respond to a gradient of mating pheromone by oriented growth along this gradient ([@B65]). Such chemotropic growth is essential for efficient mating ([@B25]; [@B72]; [@B49]). During oriented growth, the actin cytoskeleton and secretory apparatus polarize towards the tip of the mating projection ([@B6]; [@B59]). As a result cell wall and plasma membrane material is deposited at the tip of this pear-shaped cell known as a shmoo ([@B42]; [@B71]). Pheromone receptors and the heterotrimeric G-protein composed of Gα (*GPA1*), Gβ (*STE4*), and Gγ (*STE18*) are required for chemotropic growth ([@B34]; [@B64]; [@B74]). Certain alleles of the cyclin-dependent kinase inhibitor *FAR1*, such as *far1-H7* ([@B72]), and of the GDP-GTP exchange factor for the small GTPase Cdc42p *CDC24*, such as *cdc24-m1* ([@B49]), are specifically defective in chemotropic growth. These mutants are unable to orient in a pheromone gradient and select a site for mating projection growth adjacent to their previous bud site. Similarly, in the presence of saturating uniform concentrations of mating pheromone, shmoo formation occurs next to the previous bud site ([@B44]; [@B25]). The latter process has been referred to as default mating ([@B25]).

During vegetative growth, haploid cells bud at a specific site next to their previous bud site, resulting in a characteristic axial budding pattern ([@B16]). The *BUD* genes are required for this budding pattern ([@B15]; [@B26]). During budding, cells polarize their actin cytoskeleton ([@B1]; [@B37]) and secretory apparatus towards the bud site ([@B70]; [@B29]). However, this internal signal generated during budding is overridden upon exposure to a mating pheromone gradient, allowing cells to orient growth towards their mating partner ([@B44]). How cells switch from an internally programmed polarized growth process to a process dictated by an external cue is unknown.

The pheromone receptors and the heterotrimeric G-protein are also required for cell cycle arrest, mitogen-activated protein (MAP)^1^-kinase--mediated gene induction, and cell morphological changes during mating ([@B68]; [@B18]; [@B38]). Genetic studies indicate that Gβγ activates all these processes ([@B73]) with Gα having a negative regulatory role ([@B22]; [@B48]). By analogy to other G-protein coupled receptors, receptor activation results in dissociation of Gα from Gβγ. Gβγ is found as a complex at the plasma membrane ([@B33]).

Previously we have shown that an association between Gβγ and Cdc24p is involved in oriented growth during mating ([@B49]). We now show this Cdc24p--Gβ complex also contains Far1p. Genetic studies are consistent with the involvement of Far1p in this complex. Cdc24p localizes to sites of polarized growth in shmooing cells, suggesting that the complex is localized. In the absence of growth orientation mediated by this complex, cells form a mating projection adjacent to the bud site in a manner that is dependent on *BUD1*, suggesting Bud1p can regulate Cdc24p when chemotropic signaling is blocked. Together our results suggest that Cdc24p-Far1p-Gβγ acts as a landmark for cytoskeleton orientation in response to a pheromone gradient.

Materials and Methods {#MaterialsMethods}
=====================

General Techniques
------------------

Standard techniques and media were used for growth and genetic manipulation of yeast ([@B61]). Unless otherwise indicated, yeast cells were grown at 30°C.

Strains and Plasmids
--------------------

The yeast strains used in this study are described in Table [I](#TI){ref-type="table"}. In general, deletion mutants were constructed by PCR-based gene disruption as described ([@B3]; [@B49]). *ΔFar1* strains were constructed either by PCR-based gene disruption (*Δ-1*) or with a knockout cassette (*Δ-2*). This cassette contained the *FAR1* ORF followed by 100 bp 3′ sequence with *URA3Kl* replacing all but the first 109 codons. *Far1-H7*, a *far1* allele with a truncated COOH terminus ([@B72]), was constructed by replacing codons 757--830 of *FAR1* with a stop codon followed either by *HIS5Sp* or *URA3Kl*. Gene disruptions were confirmed by PCR and phenotype including mating defects with wild-type and enfeebled testers, mating pheromone growth arrest, and budding pattern. The *Δbud1 cdc24-m1* double mutant was crossed with appropriate wild-type haploid and random spore analyses demonstrated that the inability to shmoo in the presence of pheromone specifically segregated with *Δbud1 cdc24-m1* and this mating defect was observed in both mating types.

A single HA epitope (amino acids YPYDVPDYA) was added to the NH~2~ terminus of *STE4* by PCR. *HASTE4* (including 394 bp 5′ upstream of the ATG) was cloned into pRS406 and two-step gene replacement ([@B63]) of *STE4* was used to construct RAY910. Protein A--tagged Far1p (RAY1258 and RAY1336) and Ste4p (RAY1276) strains were constructed by PCR-based gene replacement using pZZ-His5 ([@B58]) as template and oligonucleotides with 60 nucleotides 5′ and 3′ of the termination codon. Myc epitope-tagged Cdc24p and cdc24-m1p strains were constructed by PCR-mediated gene replacement as described ([@B49]) except the sequence encoding a triple myc tag (MEQKLISEEDL MEQKLISEEDL MEQKLISEEDL) was directly fused to the Cdc24p NH~2~ terminus. Gene replacements were confirmed by PCR and expression of epitope-tagged proteins of the correct size by immunoblotting using either 12CA5 (anti-HA) mAB tissue culture supernatant at 1:40 dilution, anti-protein A mAb (Sigma) at 1:2,000 dilution, or anti-myc polyclonal serum (Santa Cruz) at 1:500 dilution followed by ECL (Amersham). Strains with tagged proteins mated with wild-type mating efficiencies and arrested growth normally in response to α-factor.

Cdc24HAGFP was constructed by fusing an HA epitope followed by PacI, SphI, NotI, and SacII restriction sites to the COOH terminus of Cdc24p using PCR and p414Cdc24 ([@B49]) as a template. This resulted in p414Cdc24HA which had the amino acids YPYDVPDYAGLIKHARPPPRG fused to the COOH terminus. Yeast enhanced green fluorescent protein (GFP; [@B20]) followed by the ADH terminator was PCR amplified from pMK199 (a gift from E. Schiebel) with an oligonucleotide that added a PacI site at the 5′ end and a NotI site at the 3′ end. This PCR product was cloned into p414Cdc24HA using PacI and NotI sites resulting in Cdc24p followed by YPYDVPDYAGLIKGSGAGAGAGAGA fused to GFP followed by the ADH terminator (p414Cdc24HAGFP). p416GalHASte4 was constructed by cloning *HASTE4* into pRS416 containing the Gal1/10 promoter.

The *ADE2* gene from pSP73Ade2 (cloned by PCR from genomic DNA with oligonucleotides that added an EcoRI site at the 3′ end and a XhoI site at the 5′ end) was released by digestion with EcoRI and BsrGI followed by blunting. This fragment was cloned into pRS425 in which the *LEU2* gene had been removed by digestion with Tth111I and NaeI followed by blunting resulting in p2μA. TPI-*STE18* (triose phosphate isomerase promoter) from p416TSte18 (pRS416 with TPI cloned into the SacII EagI sites and *STE18* cloned into BamHI EcoRI sites) was cloned into the SacI EcoRI sites of p2μA resulting in p2μATSte18. An oligonucleotide encoding the *GAL4* nuclear localization signal (NLS) MDKAELIPEPPKKKRKVEL followed by a NcoI restriction site was cloned into EagI BamHI sites of p2μATSte18 yielding p2μATNLSSte18. Subsequently, an oligonucleotide encoding an HA epitope tag was cloned into the NcoI BamHI sites resulting in the following NLS-HA sequence,

MDKAELIPEPPKKKRKVELPWMYPYDVPDYA fused to the NH~2~ terminus of Ste18p yielding p2μATNLSHASte18. An EcoRI SacI fragment of p2μATNLSHASte18 containing TPI-NLSHA-*STE18* was then cloned into pRS413 resulting in p413TNLSHASte18. *STE18* was removed from this vector by digestion with BamHI and EcoRI and replaced with the coding sequence of *FAR1* from pGAD424Far1 (see below) yielding p413TNLSHAFar1.

The coding sequences of the entire *FAR1* ORF and *far1-H7* were amplified by PCR from genomic DNA and cloned into pGAD424. SpeI PstI fragments of *FAR1* and *far1-H7* from pGAD424 plasmids were cloned into pMal-c2 (New England Biolabs) resulting in pMFar1 (amino acid residues 133--831) and pMFar1H7 (amino acid residues 133--756). pMFar1ΔN (amino acid residues 638--831) and pMFar1ΔC (amino acid residues 133-- 297) were derived from pMFar1 by removal of a BamHI or HindIII fragment, respectively. pMFar1H7ΔN (amino acid residues 638--756) was derived from pMFar1H7 by removal of a BamHI fragment. GSTCdc24 is comprised of the NH~2~-terminal 472 amino acids of Cdc24p fused to GST as described ([@B49]).

Two-Hybrid
----------

Two-hybrid interactions were tested by growth on SC-leu-trp-his as described ([@B49]). Identical results were obtained with at least three transformants.

Expression of a LacZ reporter from Y187 derived two-hybrid strains was quantified by β-galactosidase assays ([@B47]). An EcoRI site was inserted by oligonucleotide-directed mutagenesis after amino acid 153 of Spa2p ([@B3]). This 153--amino acid Spa2p fragment was then cloned into pGAD424. PJ69-4A *cdc24-m1* (RAY1449) was constructed by PCR-mediated gene replacement as described ([@B49]) and confirmed by PCR and mating defect phenotype. Three independent PJ69-4A *cdc24-m1* strains were used for two-hybrid analyses. Because *TRP1* is used to replace *CDC24* with *cdc24-m1*, *STE4* cloned into the 2μ *URA3 GAL4* DBD vector pGBDU-C1 ([@B35]) was used in this strain. Diploid two-hybrid strains were constructed by transformation of either DBD fusions or AD fusions along with p2μAT and p413T plasmids into SFY526 or Y187 and crossing these strains. After two-hybrid assays, phenotypes (diploid state and sterility) of diploid and haploid deletion two-hybrid strains were confirmed. Expression of NLSHAFar1p and NLSHASte18p in two-hybrid strains were confirmed by analysis of yeast extracts using SDS-PAGE, immunoblotting, probing with 12CA5 mAb, and ECL visualization.

Immunoprecipitation
-------------------

RAY1254, RAY1258, RAY1260, and RAY1336 cells carrying p416GalHASte4 were grown to an OD~600~ of 0.5 in SC-ura with 2% (wt/vol) raffinose, galactose was added to a final concentration of 2% (wt/vol) and the cultures grown for 4 h. All subsequent steps were carried out at 4°C. Cells were harvested by centrifugation, and lysed by agitation with glass beads in buffer A (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM PMSF, 40 μg/ml each of leupeptin, chymostatin, pepstatin A, aprotinin, and antipain) containing 0.1% Triton X-100. Before use IgG--Sepharose was cross-linked with dimethylpimelimidate (Sigma; [@B31]). Cell extracts were clarified by two centrifugations (10,000 *g* for 10 min). Supernatants, which contained the majority of the tagged proteins, were incubated with 20 μl of IgG-Sepharose (Pharmacia) equilibrated in buffer A containing 0.1% Triton X-100 for 1 h. Resin was then washed four times with buffer A containing 0.1% Triton X-100 and Far1-protein A fusions were specifically eluted by incubation with 20 U of TEV-protease (Boehringer Mannheim) for 4 h at 16°C in the same buffer. Eluates were analyzed by SDS-PAGE and immunoblotting using polyclonal sera against myc and Far1p (a gift from M. Peter) at 1:1,000 dilution followed visualization with ECL.

Protein Purification
--------------------

All purification steps were carried out at 4°C. MBP and GST fusion proteins were expressed in *E*. *coli* with MBPFar1 and MBPFar1-H7 bacteria grown at 30°C. Cells were resuspended in buffer B (PBS, 1 mM DTT, 0.1% Triton X-100), frozen in liquid N~2~ and stored at −70°C. Cells were lysed by sonication in buffer B with 1 mM PMSF. Extracts were clarified by centrifugation (10,000 *g* for 10 min) and fusion proteins were isolated using glutathione-agarose (Sigma) or amylose resin (New England Biolabs). MBP fusion proteins were eluted with 10 mM maltose in buffer B and dialyzed against buffer C (50 mM Tris-HCl pH 7.4, 10 mM MgCl~2~, 1 mM DTT, 10% \[vol/vol\] glycerol). Protein concentrations were determined by the Bradford method or by comparing intensities of bands on Coomassie stained SDS-PAGE gels with BSA (Sigma) as a standard. For both MBPFar1 and MBPFar1-H7, concentrations used refer to the full-length protein and not proteolytic breakdown products.

HASte4-(TEV)-protein A was purified from RAY1276 cells using IgG-Sepharose under conditions similar to those described in ([@B67]). Cells were grown in YEPD to an OD~600~ of ∼3, harvested by centrifugation, resuspended in 20 mM Tris-HCl pH 7.4 with 50 mM NaCl at ∼300 OD~600~/ml, snap frozen in liquid N~2~, and stored at −70°C. Typically 2,500 OD~600~ of cells were broken in buffer D (buffer A containing 2 mM EDTA and 3 mM MgCl~2~) by agitation with glass beads. Triton X-100 was added to cell extracts at a final concentration of 1%. After 1 h incubation the extract was centrifuged at 10,000 *g* for 20 min. The supernatant was incubated overnight with 250 μl IgG-Sepharose equilibrated in buffer D containing 1% Triton X-100. The resin was collected by centrifugation, washed once with buffer D containing 1% Triton X-100 and twice with buffer D containing 0.1% Triton X-100. HASte4p was specifically eluted by incubation with 20 U of TEV-protease in 400 μl buffer D containing 0.1% Triton X-100 for 5 h. Comparison of the amounts of total protein and HASte4p in yeast extracts (treated with TEV-protease) and eluted HASte4p preparations indicated that HASte4p was enriched over 1,000-fold in comparison to cell extracts. By immunoblotting both 3xmycCdc24p and Far1p were undetectable in HASte4p preparations (\<0.01% of the starting level).

Binding Studies
---------------

Binding experiments were all carried out at 4°C. For binding of GSTCdc24 and MBP fusion proteins ∼10 μg of GSTCdc24 bound to glutathione-agarose was incubated with respective MBP fusion proteins in 100 μl of buffer C overnight. Glutathione-agarose samples were washed twice with 1 ml of buffer C and once with 1 ml of buffer B. Proteins were eluted with SDS-PAGE sample buffer and analyzed by SDS-PAGE followed by Coomassie blue staining or transfer to nitrocellulose, probing with anti-MBP mAb (Sigma) at 1:4,000 dilution and visualized by ECL. For binding experiments with yeast HASte4p, the HASte4p preparation was diluted 10-fold into buffer C and 100 μl was incubated with either resin bound GST or MBP fusions. MBP fusions were bound to amylose resin by incubation of ∼5 μg of each protein with 20 μl of amylose resin for 1 h. GSTCdc24--MBPFar1 was prepared by passing a bacterial extract (from 100 ml of cells) containing GSTCdc24 over a column with ∼500 μg of MBPFar1 bound to amylose resin. The column was washed with buffer B and then GSTCdc24--MBPFar1 was eluted with buffer B containing 10 mM maltose. The eluate was incubated with glutathione-agarose for 30 min which was then washed three times with buffer B. Proteins bound to the resin were analyzed by SDS-PAGE and Coomassie blue staining or used for HASte4p binding.

Mating and Pheromone Response Assays
------------------------------------

Quantitative matings were carried out as described in ([@B3]; [@B49]) with Mat**a** cells as indicated and Matα RAY1135 cells. Pheromone induced cell cycle arrest and induction of a Fus1LacZ reporter were assayed as described ([@B49]). For pheromone treatment ∼0.2 OD~600~of log-phase cells were collected by centrifugation, resuspended in 2 ml YEPD containing 12 μM α-factor (synthesized by David Owen, MRC LMB) and incubated for 3 h. Cells were fixed with formaldehyde and actin was visualized as described ([@B49]) using rhodamine phalloidin (Molecular Probes). To examine cell morphologies in mating mixtures, Mat**a** cells were stained with 10 μg/ml Calcofluor white ([@B55]) (Sigma) in YEPD for 5 min at rt and subsequently washed extensively with YEPD. Approximately 5 × 10^6^ stained cells were then mixed with unstained Mat**a** (RAY1135) cells and incubated on filters. After 2 h cells were washed from the filters, briefly sonicated, resuspended in PBS and fixed with formaldehyde. Images of cells were taken using a Zeiss Axioskop microscope with either a NA 1.4 ×63 or NA 1.3 ×100 objective and recorded with a Princeton Instrument Micromax CCD camera. Fluorescence and differential interference-contrast (DIC) images were merged to permit identification of Mat**a** cells.

Localization of Cdc24p
----------------------

Cdc24HAGFP (p414Cdc24HAGFP) was transformed into RAY931 which is deleted for *CDC24* and kept alive by the rescuing plasmid pEG(KT)Cdc24 ([@B49]). This strain was able to lose the rescuing plasmid (both by extensive growth in SC-trp media or counter-selection on 5-FOA) as determined by markers and PCR, resulting in RAY1360, indicating that Cdc24HAGFP was functional. RAY1360 grew normally at 22°C, 30°C, and 37°C on YEPD plates. Budding patterns were determined as described ([@B3]) and mating efficiency was determined as described above. Cdc24HAGFP expression and size was verified by SDS-PAGE, immunoblotting, probing with 12CA5 mAb and ECL visualization. Confocal microscopy was carried out as described ([@B3]) except cells were grown in SC supplemented with 55 μg/ml adenine to reduce fluorescence due to *ade2*. Pheromone treatment was with 140 μM α-factor. Cells were imaged after 1 h in order to observe early localization. For latrunculin A treatment of budding cells 2 μl of either 10 mM latrunculin A (Molecular Probes) in DMSO or DMSO was added to 200 μl of log-phase cells (final concentration latrunculin A 0.1 mM) and cells were incubated for 3 h ([@B5]). For latrunculin A treatment of shmoos, cells were incubated with 140 μM α-factor for 1 h and then 0.1 mM latrunculin A or DMSO was added to cells which were incubated for 2 h. After observation by confocal microscopy, actin depolymerization was confirmed by staining fixed cells with rhodamine phalloidin as described above.

Results {#Results}
=======

The Cdc24p--Gβγ Interaction Requires FAR1 but Not Pheromone-dependent Signaling
-------------------------------------------------------------------------------

*Cdc24-m* alleles are defective in growth orientation along a pheromone gradient, yet do not affect pheromone-dependent MAP-kinase pathway signaling ([@B49]). These mutants are also unable to interact with Gβ (Ste4p) in two-hybrid assays. In Cdc24p--Gβ two-hybrid assays Gβ was overexpressed, which has been shown to activate the MAP-kinase pathway ([@B73]). Hence it was possible that MAP-kinase signaling is required for this interaction. Two-hybrid experiments revealed that while Cdc24p and Gβ interact in a haploid strain, no detectable interaction was observed in a diploid (compare Fig. [1](#F1){ref-type="fig"}, A and B), in which several mating specific proteins, including Gγ (Ste18p), are not expressed ([@B68]). Gγ is required for this interaction in a haploid ([@B49]). Surprisingly, overexpression of Gγ in a diploid did not restore the Cdc24p--Gβ interaction, whereas overexpression of Gγ in a *Δste18* haploid restored this interaction (Table [II](#TII){ref-type="table"}). This result is consistent with the notion that either a haploid specific component and/or pheromone-dependent signaling is required for the Cdc24p--Gβγ interaction.

To examine the role of the pheromone-dependent MAP- kinase pathway in the Cdc24p--Gβγ interaction, two-hybrid strains were constructed in which each component of this pathway was deleted. The MAP-kinase scaffolding protein Ste5p, the PAK kinase Ste20p which phosphorylates Ste11p, the MAPKKK Ste11p, the MAPKK Ste7p, the MAPK Fus3p or Kss1p, and the transcription factor Ste12p were each individually disrupted in a two-hybrid strain. In addition, the Ste20p homologue Skm1p, the cyclin-dependent kinase inhibitor required for α-factor cell cycle arrest Far1p, the polarity establishment protein Bem1p, the Gβγ effector Akr1p, and the bipolar bud site selection protein Bud6p were deleted from this strain. Several of these proteins including Ste5p, Fus3p, and Far1p are only expressed in haploids ([@B68]) and thus are candidates for haploid specific components required for the Cdc24p--Gβγ interaction. Deletion of *SKM1*, *BEM1*, *AKR1*, or *BUD6* had no effect on the Cdc24p--Gβ interaction. In contrast, removal of any component of the pheromone-dependent MAP-kinase pathway (with the exception of Fus3p and Kss1p which are functionally redundant for mating) resulted in the loss of the Cdc24p--Gβ two-hybrid interaction. Because Gγ appeared to be required for the Cdc24p--Gβ interaction ([@B49]), we examined whether overexpression of Gγ was able to restore the Cdc24p--Gβ interaction in these strains. Table [II](#TII){ref-type="table"} shows that overexpression of Gγ partially restored the Cdc24p--Gβ interaction in *Δste5*, *Δste11*, and *Δste7* strains and to a lesser extent in *Δste20* and *Δste12* strains. These results indicate that signaling through the pheromone-dependent MAP-kinase cascade per se is not required for the Cdc24p--Gβγ interaction. However, deletion of *FAR1* resulted in a loss of the Cdc24p--Gβ interaction which was not restored upon overexpression of Gγ (Table [II](#TII){ref-type="table"} and Fig. [1](#F1){ref-type="fig"} C), suggesting that Far1p may be essential for this interaction.

The requirement for Gγ and Far1p in the Cdc24p--Gβ two-hybrid interaction suggested an explanation for the low level of LacZ reporter activity observed in the haploid Y187 two-hybrid strain and the absence of an interaction in the diploid two-hybrid strain, namely that these two proteins were limiting in haploids and absent in diploids. To test this possibility, we overexpressed Gγ and Far1p individually and together in the Y187 haploid two-hybrid strain. Fig. [1](#F1){ref-type="fig"} A shows that overexpression of Gγ in the presence of pAS1Cdc24 and pGAD424Ste4 resulted in an approximately twofold increase in LacZ activity, whereas the additional overexpression of Far1p resulted in a further increase in LacZ activity by ∼3.5-fold. In diploids, overexpression of Gγ did not result in a Cdc24p--Gβ interaction. However overexpression of Far1p resulted in LacZ reporter activity (Fig. [1](#F1){ref-type="fig"} B) and this was further increased by additional overexpression of Gγ, suggesting that in the absence of pheromone-dependent signaling Far1p is sufficient for restoring the Cdc24p--Gβγ interaction.

*FAR1* is necessary for both pheromone-dependent growth arrest and oriented growth towards a pheromone gradient ([@B13]; [@B72]). These two functions of *FAR1* can be separated, with the Far1p NH~2~ terminus necessary for cell cycle arrest and the COOH terminus necessary for growth orientation. Our two-hybrid results indicate *FAR1* is necessary for the Cdc24p--Gβ interaction, yet it is unclear which function of *FAR1* this corresponds to. Because *cdc24-m* and *far1-s* appear phenotypically identical and both exhibit orientation defects ([@B72]; [@B49]), we examined the effect of the *far1-s* allele *far1-H7* on this interaction. This *far1* mutation results in a COOH-terminal 75-- amino acid deletion and despite its orientation defect is normal for cell cycle arrest. Fig. [1](#F1){ref-type="fig"} C shows that a *far1-H7* mutation prevents the Cdc24p--Gβ interaction. These results suggest that the *FAR1* orientation function is required for the Cdc24p--Gβ association, consistent with the role of this interaction in growth orientation.

We next investigated whether Far1p interacted with Cdc24p and Gβ. Fig. [1](#F1){ref-type="fig"} and Table [III](#TIII){ref-type="table"} show that in two-hybrid assays Far1p can interact with both Cdc24p and Gβ. The Cdc24p--Far1p interaction was observed in strains deleted for *STE4*, *STE18*, *FUS3*, or *STE12*, indicating that it does not require Gβγ nor pheromone-dependent MAP-kinase signaling (including Fus3p-dependent phosphorylation of Far1p). Similarly, the Far1p--Gβ interaction did not require *STE18*, *FUS3*, or *STE12*. The Far1p--Gβ interaction also did not require the *CDC24* orientation function as we observed this interaction in a *cdc24-m1* two-hybrid strain. In addition we examined Cdc24-m1p, which we had previously shown does not interact with Gβ, and found that Cdc24-m1p also did not interact with Far1p (data not shown). Together these results suggest that Far1p and Cdc24p can associate and this association is independent of pheromone signaling.

Far1p Binds Cdc24p
------------------

To further investigate these interactions epitope-tagged versions of Far1p and Cdc24p were constructed. Myc and protein A domains were fused to Cdc24p and Far1p, respectively and these fusions were used to replace wild-type genes. Far1-protein A fusions had a tobacco etch virus (TEV) protease cleavage site between Far1p and protein A to allow specific elution. These strains grew normally and exhibited normal vegetative morphology. Furthermore, both fusions mated with similar efficiencies as a wild-type strain when crossed to a wild-type tester or to an enfeebled tester. Far1-protein A fusions promoted normal cell cycle arrest and cells carrying this fusion formed shmoos that appeared normal upon exposure to mating pheromone. Together these results indicated that the fusion proteins were functional. Fig. [2](#F2){ref-type="fig"} shows that when Far1-protein A was isolated with IgG-Sepharose, myc-tagged Cdc24p was bound (compare lanes 1 and 2 with 3 and 4). When Cdc24p or Far1p orientation mutants were used, a substantial decrease in the amount of Cdc24p bound to Far1p was observed in both cases (lanes 5--8). These results reveal the molecular basis for the similar phenotypes of *cdc24-m1* and *far1-H7* mutants. Although two-hybrid results indicated a Far1p--Gβ association, this was apparently not stable enough to observe by immunoprecipitation.

To address whether these protein interactions were direct, binding experiments were carried out using purified proteins. Far1p and the NH~2~-terminal half of Cdc24p (amino acids 1--472; [@B49]) were purified from bacteria as fusions to maltose binding protein (MBP) and glutathione-*S*-transferase (GST), respectively. Fig. [3](#F3){ref-type="fig"} A shows that MBPFar1 bound GSTCdc24 but not GST alone. MBPFar1-H7 (Fig. [4](#F4){ref-type="fig"} A) does not significantly bind GSTCdc24p, consistent with immunoprecipitation results above (Fig. [2](#F2){ref-type="fig"}). In these binding experiments an excess of GSTCdc24 is used and an increase in MBPFar1 binding occurs as its concentration in the binding reaction is increased (Fig. [3](#F3){ref-type="fig"} B). These results demonstrate that Far1p can bind Cdc24p directly in the absence of other proteins.

These binding studies demonstrated that the COOH terminus of Far1p is necessary for GSTCdc24 binding, hence we examined if this region was also sufficient for binding. Fig. [4](#F4){ref-type="fig"} B shows that a 200--amino acid Far1p COOH-terminal fragment (lane 10) is not sufficient for GSTCdc24 binding and furthermore an NH~2~-terminal Far1p fragment did not bind GSTCdc24 (lane 9). MBPFar1-H7 and MBPFar1ΔC, which do not bind GSTCdc24 are unlikely to be grossly misfolded as they retain the ability to bind Gβ (see below). These results indicate that although the COOH terminus of Far1p is necessary for binding Cdc24p it is not sufficient. An immunoblot of the MBPFar1 bound to GSTCdc24 (Fig. [4](#F4){ref-type="fig"} B, lane 7) revealed that proteolytic fragments of Far1 with as little as 25 kD of the NH~2~-terminus (approximately residues 133--350) are coprecipitated with MBPFar1 and GSTCdc24. This region of Far1p, which includes a Lim domain ([@B62]), does not bind Cdc24p directly (Fig. [4](#F4){ref-type="fig"} B, lane 9), suggesting that this region may mediate Far1p multimerization.

Far1p Binds Gβ
--------------

Hemagglutinin (HA)-tagged Gβ (Ste4p) was purified from yeast in order to examine its binding to MBPFar1 (Fig. [4](#F4){ref-type="fig"} C). For this purpose a strain in which the wild-type copy of *STE4* was replaced with HASte4-(TEV)-protein A was used. This fusion was functional for mating and cell cycle arrest. The Ste4p fusion was isolated with IgG-Sepharose and eluted by specific cleavage between Ste4p and the protein A domains using TEV protease, yielding HASte4p which was over 1,000-fold enriched compared with cell extracts. This HASte4p preparation had undetectable levels of Far1p and Cdc24p (\<0.01% of the starting level, data not shown). Aliquots of HASte4p were incubated with various MBPFar1 fragments immobilized on amylose resin and bound HASte4p was analyzed by SDS-PAGE and immunoblotting. Fig. [4](#F4){ref-type="fig"} C shows that HASte4p bound equally well to MBPFar1 and MBPFar1-H7 (lanes 2 and 3), whereas both NH~2~- and COOH-terminal Far1p fragments bound substantially less HASte4p (lanes 4--6). Of these smaller Far1p fragments, only Far1ΔC (amino acid residues 133--297) bound substantial amounts of HASte4p, suggesting that this region which includes the Lim domain is involved in Gβ binding. These experiments show that Gβ can bind Far1p in the absence of Cdc24p and suggest that perhaps Gβ and Cdc24p bind to different regions of Far1p.

A Cdc24p-Far1p-Gβ Complex
-------------------------

Since both Cdc24p and Far1p bind Gβ, we addressed whether the addition of MBPFar1 to GSTCdc24 bound to glutathione-agarose could compete for HASte4p (Gβ) binding. Fig. [5](#F5){ref-type="fig"} A shows that addition of MBPFar1 did not prevent HASte4p binding to GSTCdc24 (compare lanes 1 and 2 with 3 and 4), but rather increased binding by about twofold. Coomassie blue staining of glutathione-agarose eluates revealed that MBPFar1 bound GSTCdc24. These results indicate that Far1p binding to Cdc24p does not displace Gβ, and are consistent with the formation of a complex of all three proteins.

To directly test whether a complex of all three proteins could form we determined whether a stoichiometric complex of Cdc24p--Far1p could bind Gβ (Ste4p). GSTCdc24-- MBPFar1 was isolated by sequential purification using amylose and glutathione resin. Fig. [5](#F5){ref-type="fig"} B shows that GSTCdc24--MBPFar1 contained roughly equal amounts of these two fusion proteins. Purified HASte4p was then incubated either with this complex or GSTCdc24 alone. Densitometric quantification showed that twofold more HASte4p bound to Cdc24p--Far1p (Fig. [5](#F5){ref-type="fig"} B compare lanes 1 and 2) than to a similar amount of Cdc24p alone, demonstrating that trimeric Cdc24p-Far1p-Gβ can form. This increase in Gβ binding does not appear to be cooperative and is more likely to be the sum of contributions from Cdc24p and Far1p. Because both Far1p and Cdc24p can individually bind each other or Gβ it is likely that in a trimeric complex each protein contacts the other two proteins. These binding studies together with the two-hybrid results suggest that Cdc24p-Far1p-Gβ is necessary for mating projection orientation.

Cdc24p and Far1p Function in the Same Shmoo Orientation Process
---------------------------------------------------------------

To examine if *CDC24* and *FAR1* function in the same process we compared the mating efficiencies of both single and double *Δfar1* and *cdc24-m1* mutants. Fig. [6](#F6){ref-type="fig"} shows that the presence of a *cdc24-m1* mutation in a *Δfar1* background did not result in a further decrease in mating efficiency, suggesting that *FAR1* and *CDC24* function in the same orientation process. The mating defect of the double mutant is closer to that of the *Δfar1* mutant that in addition to a chemotropism defect does not arrest growth in response to mating pheromone. If *cdc24-m1* affected chemotropism similarly to *Δfar1*, then a double mutant with *Δspa2*, a gene required for the default mating pathway ([@B25]), should have a mating defect greater than the product of the individual mating defects, a phenomenon known as synthetic sterility ([@B25]). Fig. [6](#F6){ref-type="fig"} shows that *Δspa2 cdc24-m1* mutants exhibited synthetic sterility.

We also examined genetic interactions between *cdc24*- *m1* and *Δbem1* or *Δste20*, two genes involved in polarized growth and mating. Bem1p is associated with the cytoskeleton ([@B40]), binds Cdc24p ([@B54]; [@B76]), and Far1p ([@B43]). *Bem1* mutants are unable to form shmoos and instead form round cells in the presence of mating pheromone ([@B19]). *ΔBem1 cdc24-m1* cells showed similar temperature sensitive growth and morphological defects (large round cells) as *Δbem1* cells, providing further evidence that *cdc24-m1* has no effect on vegetative growth. Even in cells lacking *BEM1* which cannot form shmoos, *cdc24-m1* resulted in a substantial decrease in mating efficiency (Fig. [6](#F6){ref-type="fig"}), i.e., synthetic sterility. Because deletion of the PAK kinase *STE20* in our strain background did not result in complete sterility, we were able to examine the mating defect of *Δste20* cells in the presence and absence *cdc24-m1*. In the absence of *STE20*, *cdc24-m1* resulted in a further decrease in mating efficiency. Together these results suggest that in *Δbem1* and *Δste20* mutants, which are unable to form shmoos, polarization may still be necessary for mating perhaps for the localization of proteins necessary for cell fusion. Furthermore, because *BEM1* and *STE20* are not required for default mating ([@B24]), such synthetic mating defects with *cdc24-m1* are consistent with a genetic linkage between shmoo formation and orientation.

Cdc24p Localization
-------------------

If Cdc24p transmits signals from bud site selection proteins or Gβγ, it might be localized to regions of polarized growth. We therefore examined the localization of a Cdc24p green fluorescent protein (GFP) fusion. Cdc24HAGFP expressed from its own promoter on a CEN plasmid complemented *Δcdc24* as determined by growth at different temperatures, budding patterns, and mating efficiencies (data not shown). Fig. [7](#F7){ref-type="fig"} A shows the localization of Cdc24HAGFP in living cells at different stages in the cell cycle. In unbudded cells Cdc24p localized as a tight patch at the membrane, and in cells with small buds at the growing end. In larger buds, this localization became more spread out. Finally, during cytokinesis Cdc24p generally localized to the mother-bud neck. Curiously, a preliminary report showed that an overexpressed GSTCdc24 fusion protein had a circumcellular distribution in budding cells ([@B56]). Cdc24HAGFP also localized to sites of polarized growth after α-factor treatment. Fig. [7](#F7){ref-type="fig"} B shows different shmoos in which Cdc24HAGFP is observed as a patch at the tip of the mating projection. Cdc24HAGFP was localized similarly in mating mixtures (data not shown). Furthermore, as the sole copy of Cdc24p in a *Δcdc24* strain, Cdc24-m1HAGFP also localized to sites of polarized growth in budding and mating cells (data not shown), indicating that this mutant is not defective in its localization to sites of polarized growth. These data demonstrate that Cdc24p localizes to sites of polarized growth.

The early localization of Cdc24p in the cell cycle and its localization to the shmoo tip are consistent with its function in polarity establishment. The localization of Cdc24p is similar to that of its substrate Cdc42p ([@B77]). To determine whether the actin cytoskeleton was necessary for polarized Cdc24p localization, budding and shmooing cells were treated with the actin depolymerizing drug latrunculin A ([@B5]). Fig. [8](#F8){ref-type="fig"} A shows that even in the absence of actin polymerization, Cdc24p is localized to sites of polarized growth in budding cells. In contrast, latrunculin A treatment of shmoos resulted in a substantial decrease in Cdc24p localization (Fig. [8](#F8){ref-type="fig"} B). Upon latrunculin A treatment the number of cells with Cdc24p localized to the shmoo tip decreased by fivefold (*n* = 100) and in cells that exhibited localized Cdc24p, there appeared to be a decrease in the amount of Cdc24HAGFP localized to the shmoo tip and an increase in fluorescence throughout the cell. These results are consistent with the effects of latrunculin A on Cdc42p localization in budding and shmooing cells ([@B5]; [@B4]).

In the Absence of CDC24- or FAR1-mediated Chemotropism the Bud Site Selection Machinery Is Essential for Shmoo Formation
------------------------------------------------------------------------------------------------------------------------

During mating, a pheromone gradient serves as the external cue for growth orientation. This external signal allows haploid cells to orient growth in a pheromone gradient emanating from any direction ([@B44]), whereas the site for bud formation in haploids is fixed adjacent to the previous bud site ([@B16]). The selection of a site for the mating projection must override the fixed location of the bud. If Cdc24p acts as a switch between internal signals during budding and external signals during mating ([@B49]), we would predict that bud site selection proteins become important for cell mating when the capacity for shmoo orientation is lost in mutants such as *cdc24-m1*.

The ras related small G-protein Bud1p/Rsr1p is essential for bud site selection, yet is not required for chemotropic or default mating in saturating pheromone ([@B60]; [@B24]). However Bud1p can directly associate with Cdc24p ([@B76]; [@B52]) and this association is likely to be functionally important ([@B7]; [@B46]). We therefore examined the phenotype of *Δbud1 cdc24-m1* double mutants to determine if the loss of *CDC24*-mediated chemotropism caused a *BUD1*-dependent mating defect. Both *Δbud1* and *Δbud1 cdc24-m1* cells grew normally, were not temperature sensitive for growth, and had the expected random budding pattern (data not shown). Strikingly, the *Δbud1 cdc24-m1* double mutant showed a stronger mating defect (an eightfold further decrease in mating efficiency) than *cdc24-m1* alone (Fig. [9](#F9){ref-type="fig"} A). In contrast, *Δbud1* alone had no effect on mating efficiency in agreement with previous studies ([@B15]; [@B24]). Microscopic observation of *Δbud1 cdc24-m1* double mutants treated with a high concentration of mating pheromone (Fig. [9](#F9){ref-type="fig"} B) or exposed to pheromone gradients in mating mixtures (Fig. [9](#F9){ref-type="fig"} C) revealed that these cells were defective in shmoo formation. Instead of forming typical pear-shaped shmoos most cells were enlarged and round. On closer inspection a small protrusion was occasionally observed on these cells. Furthermore, the actin cytoskeleton in the double mutants was depolarized, with actin cortical patches and cables disorganized (Fig. [9](#F9){ref-type="fig"} D). In contrast, both *Δbud1* and *cdc24-m1* single mutants formed shmoos. Otherwise *Δbud1 cdc24-m1* double mutants responded normally to pheromone by undergoing cell cycle arrest and pheromone-dependent gene induction (data not shown). These results suggest that in the absence of chemotropism, *BUD1* and perhaps the bud site selection machinery becomes essential for shmoo formation. Surprisingly, in saturating uniform concentrations of mating pheromone *Δbud1* does not result in a mating defect ([@B24]), raising the possibility that this novel role of *BUD1* is revealed specifically when signaling from Gβγ to Cdc24p is blocked.

Our results indicate that Far1p is required for signaling from Gβγ to Cdc24p. If the shmoo formation defect of *Δbud1 cdc24-m1* cells is due to a defect in this signaling, a *Δbud1 Δfar1* double mutant should show an analogous decrease in mating efficiency. *ΔBud1 Δfar1* cells had a stronger mating defect (an eightfold decrease in mating efficiency) than *Δfar1* cells. As a control the effect of *Δbud1* was examined in a *Δsst2* strain. *ΔSst2* cells are supersensitive to mating pheromone as *SST2* negatively regulates the heterotrimeric G-protein ([@B23]). Therefore *Δsst2* cells mate as though they are saturated with mating pheromone, mating by the default pathway ([@B24]). *ΔBud1 Δsst2* cells had a similar mating defect as *Δsst2* alone, indicating that the absence of chemotropic mating by itself is not sufficient to reveal *BUD1* function in mating. These synthetic mating defects of *Δbud1* with *cdc24-m1* or *far1* show that Bud1p, which normally functions in bud site selection, can play a role in shmoo formation, presumably by regulating Cdc24p.

Discussion {#Discussion}
==========

During mating yeast cells grow in a polarized fashion towards their mating partner ([@B65]; [@B25]; [@B72]; [@B49]). Yeast cells are able to sense pheromone gradients and orient their actin cytoskeleton and secretion towards such a gradient. Here we show that a complex comprised of Cdc24p, Far1p, and Gβγ can form and is likely to be required for orientation towards a mating partner. The formation of this complex does not directly require signaling via the pheromone-dependent MAP-kinase pathway. Analyses of mating defects of double mutants indicate that *FAR1* and *CDC24* both function in the same cell orientation process. Cdc24p localizes to sites of polarized growth suggesting that Cdc24p-Far1p-Gβγ is localized. Cdc24p localization does not depend on the actin cytoskeleton during budding but does depend on the actin cytoskeleton during shmooing. In the absence of signaling from Gβγ to Cdc24p, the bud site selection protein Bud1p is required for shmoo formation, demonstrating a molecular link between growth site selection in mating and budding. Together these results suggest that binding of Gβγ to Far1p and Cdc24p creates an internal landmark for growth towards an external signal.

A Complex Comprised of Cdc24p, Far1p, and Gβγ Links External Signals to Cytoskeleton Orientation
------------------------------------------------------------------------------------------------

Detection of a pheromone gradient and orientation of growth in such a gradient is a process central to yeast mating and is analogous to *Dictyostelium* chemotaxis and nerve cell chemotropism ([@B2]). Alleles of both *far1* ([@B72]) and *cdc24* ([@B49]) are specifically defective in orientation towards a pheromone gradient. Cells mutant for the α-factor pheromone receptor (Ste2p) or the heterotrimeric G-protein, discriminate poorly between pheromone signaling and nonsignaling mating partners suggesting that these components are also required for chemotropism ([@B34]; [@B64]). *Cdc24*-*m* mutants are unable to interact with the Gβ subunit of the heterotrimeric G-protein ([@B49]). These results led to a model in which Gβγ locally activates or recruits Cdc24p, which could then activate Cdc42p and other downstream targets required for cytoskeleton orientation. We conclude from two-hybrid, binding, and genetic data that Far1p is involved in signaling from Gβγ to Cdc24p by forming a complex with these proteins.

Our two-hybrid results suggest that the Far1p--Gβ interaction does not require the *CDC24* orientation function, yet Far1p is essential for the Cdc24p--Gβ interaction. In contrast, in vitro binding experiments show that Cdc24p is able to bind to Gβ purified from bacteria ([@B49]) and yeast in the absence of Far1p. We attribute this difference between two-hybrid and in vitro binding results to the different methods used. For example, in the two-hybrid experiments interactions occur in the nucleus and on the other hand the in vitro binding studies are carried out with high concentrations of purified proteins. We suggest that although Far1p is important for the Cdc24p--Gβ interaction it is not absolutely essential, whereas Cdc24p is not necessary for the Far1p--Gβ interaction. We have demonstrated that a triple complex comprised of Cdc24p-Far1p-Gβγ can form using purified proteins and believe that in vivo this complex links receptor activation to cytoskeleton organization (Fig. [10](#F10){ref-type="fig"}). These results show at a molecular level the role of Far1p in growth orientation. Consistent with the specific phenotype of *far1* and *cdc24* orientation alleles, we find that pheromone-dependent MAP-kinase cascade signaling is not necessary for the association of this complex. This result indicates that the MAP-kinase cascade is not directly required for chemotropic growth, in agreement with recent mating partner discrimination studies ([@B64]). Furthermore, the formation of this complex does not require *FUS3*, which normally phosphorylates Far1p in a pheromone-dependent fashion ([@B14]; [@B28]). This phosphorylation of Far1p is necessary for cell cycle arrest, indicating that the cell cycle arrest function of *FAR1* is not required for interactions between Cdc24p, Far1p, and Gβγ.

How is the formation of this protein complex regulated by pheromone activation of the receptor? Pheromone binding to the receptor is believed to trigger dissociation of Gα from Gβγ. Recent studies suggest Gα binds the pheromone receptor ([@B36]; [@B45]) and that Gβγ must be membrane associated in order to function ([@B57]). GFP fused to Gγ is localized preferentially to the plasma membrane of the mating projection after pheromone treatment (Nern and Arkowitz, unpublished observation). Upon pheromone stimulation, Far1p levels increase ([@B14]; [@B72]) resulting in increased levels of Cdc24p--Far1p (Nern and Arkowitz, unpublished observation). As Far1p localizes to the nucleus during vegetative growth ([@B32]), it would appear likely that Far1p must exit the nucleus in order to carry out its mating orientation function. We envision that released Gβγ recruits Cdc24p--Far1p to the vicinity of activated receptors and Cdc24p-Far1p-Gβγ ultimately directs the cytoskeleton towards this internal landmark. Such a mechanism provides a means of translating local activation of pheromone receptors to cytoskeletal orientation. We would predict that Far1p, like Cdc24p, localizes to the tip of the mating projection in pheromone treated cells.

While this work was being reviewed a paper examining the role of Far1p in polarized growth during mating was published ([@B12]). In general, our results agree with the findings of this work. The authors postulate that Far1p functions as an adaptor or linker between Gβγ and polarity establishment proteins including Cdc24p. Our in vitro binding results indicate that even in the absence of Far1p, Gβγ can still bind Cdc24p, suggesting that perhaps Far1p is not simply a physical adaptor but may have more complex functions. Overexpressed GFPFar1 was shown to relocalize from the nucleus to the cytoplasm upon treatment with a saturating uniform concentration of pheromone for two hours. In these conditions GFPFar1 does not appear to accumulate at shmoo tips. It will be interesting to determine whether wild-type levels of Far1p localizes similarly in cells exposed to a pheromone gradient for various times.

How are these protein interactions involved in transmitting spatial information? Previous studies have indicated that in a pheromone gradient, shmoo orientation improves as a function of time ([@B65]). This appears to be due to reorientation of the shmoo tip as it grows ([@B65]; Nern and Arkowitz, unpublished observation), indicating that shmoo orientation is a continuous process unlike bud site selection. Perhaps Cdc24p-Far1p-Gβγ dissociates reasonably fast such that this complex is continually dissociating and forming. Such a dynamic process would provide a means for continuous reorientation during mating and could play a central role in translating initial small differences in receptor occupancy into oriented growth.

Another difference between bud and shmoo formation is that in budding the polarity establishment proteins Cdc42p and Bem1p localize independent of the actin cytoskeleton ([@B5]) whereas in the latter process the actin cytoskeleton is necessary for the efficient localization of these proteins ([@B4]). During shmoo formation the actin cytoskeleton requirement for localization of Cdc24p and these other polarity establishment proteins appears to be similar. Why is the actin requirement for localization of this group of proteins different in budding and shmooing cells? Perhaps the continuous nature of the shmooing process compared with the committed directional growth required for budding underlies this different dependence on the actin cytoskeleton. It will be important to examine the role of the actin cytoskeleton in cells responding to a pheromone gradient.

Coordination of Different Pheromone Responses
---------------------------------------------

Pheromone stimulation results in gene induction, cell cycle arrest, and morphological changes ([@B68]; [@B18]; [@B38]). The timing and coordination of these different responses is important for efficient mating. Our genetic studies are consistent with Cdc24p and Far1p being part of the same protein complex functioning in growth orientation and we examined two additional genes that might have a role in coordinating various pheromone responses.

The PAK kinase Ste20p is important for MAP-kinase signaling during mating. It interacts with Bem1p, Ste4p, Ste5p, and Cdc42p ([@B40]; [@B75]; [@B53]; [@B39]; [@B41]). Recent mating partner discrimination studies ([@B64]) suggest that *STE20* may not be required for chemotropism. Our two-hybrid results suggest that *STE20* has some effect on the Cdc24p--Gβ interaction, however *cdc24- m1* results in a further mating defect in *Δste20* cells. While Ste20p binds Gβ, it is unclear how this association relates to the Far1p, Cdc24p, Gβγ interaction. Further studies will be necessary to elucidate the roles of *STE20* in various aspects of mating.

Bem1p is required for polarized growth both during mating and budding ([@B8]; [@B19]). *ΔBem1* cells are defective in shmoo formation, mating pheromone-dependent cell cycle arrest and efficient signaling via the MAP-kinase cascade ([@B19]; [@B43]). At the molecular level Bem1p interacts with many components required for polarized growth such as the G-protein Bud1p ([@B76]; [@B52]), Cdc24p ([@B54]; [@B76]), Far1p ([@B43]), actin ([@B40]), Ste5p ([@B40]; [@B43]), and Ste20p ([@B40]). Although Bem1p binds both Cdc24p and Far1p, Bem1p is not required for the formation of Cdc24p-Far1p-Gβγ. Results from *Δbem1 cdc24-m1* mutants suggest that even for cells unable to form shmoos, polarization is important. Perhaps this is because the molecules necessary for cell fusion must be correctly localized. What is the molecular function of Bem1p in mating? We favor the idea that Bem1p acts as a scaffolding component linking pheromone-dependent MAP-kinase signaling, shmoo formation, and shmoo orientation.

Cdc24p as a Switch between Growth Site Selection in Mating and Budding
----------------------------------------------------------------------

An attractive model (Fig. [10](#F10){ref-type="fig"}) is that Cdc24p acts as a selector switch that responds to input signals from bud site selection ([@B66]) and mating projection orientation ([@B49]). We envision that the localization and activation of Cdc24p is essential for its function in both bud site selection and mating projection orientation. During budding it is likely that local activation of the G-protein Bud1p marks the site for bud formation ([@B17]; [@B46]). The GTP bound form of Bud1p binds Cdc24p ([@B76]; [@B52]) and this interaction may be required for Cdc24p localization to the bud site. Interactions of Cdc24p with the bud site selection machinery dictate the site of mating projection growth in the absence of local activation of Cdc24p by Gβγ, such as in the case of *far1* ([@B72]) or *cdc24* ([@B49]) mutations or in the presence of saturating mating pheromone ([@B44]; [@B25]), wherein the mating projection forms adjacent to the previous bud. We show Bud1p becomes essential for shmoo formation specifically in the absence of signaling from Gβγ to Cdc24p. This demonstrates that the bud site selection machinery can function in shmoo formation. It is surprising that under these conditions, *BUD1* functions in shmoo formation, while during budding it appears only to function in bud site selection and not bud formation. Interestingly, a specific role for *BUD2* in bud formation has been observed in triple mutant combinations with *Δcln1* and *Δcln2* ([@B10]; [@B21]). A possible explanation for these different functions of *BUD1* is that mating projection orientation is a continuous process, in contrast to bud site selection in which once a site for growth is chosen, subsequent directed growth is fixed to this site and there may no longer be a requirement for *BUD* genes.

We attribute the role of *BUD1* in shmoo formation to a synthetic effect with *cdc24*/*far1* suggesting this function of *BUD1* is normally redundant yet revealed in the absence of Gβγ-mediated chemotropism. Recently it has been proposed that *BUD1* is involved in cell fusion ([@B27]), yet the effects of *Δbud1* we observe in *cdc24-m1* mutants, i.e., the inability to form a shmoo, are unlikely to be a result of its role in fusion as we observe this morphological defect in response to mating pheromone without a mating partner. Furthermore, in contrast to the results of [@B27] but in agreement with previous studies ([@B24]), *Δbud1* does not result in a mating defect in our strain background. In addition, *Δbud1* does not affect mating in the presence of saturating uniform mating pheromone concentration ([@B24]). Therefore while both mating in the presence of saturating pheromone or mating in a *cdc24* or *far1* mutant block chemotropic growth, at the molecular level these two situations are not equivalent and this difference is consistent with the suggestion that Cdc24p must be localized or locally activated to function properly (Fig. [10](#F10){ref-type="fig"}). We imagine that during mating in saturating uniform pheromone concentrations, the Cdc24p-Far1p-Gβγ linkage is intact, but the external spatial signal is absent. In contrast, in a *cdc24-m1* or *Δfar1* mutant while the external signal is present, signaling from Gβγ to Cdc24p is prevented. Furthermore, the early localization of Cdc24p during shmoo and bud formation supports the proposed role of Cdc24p in linking a spatial landmark to polarity establishment.

A simple mechanism for growth site selection during mating and budding is that a threshold level of locally activated Cdc24p is necessary to catalyze the GDP-GTP exchange of Cdc42p. This activation of Cdc24p is presumably generated in part by Bud1p during budding and switched to the region of the cell adjacent to the pheromone source by released Gβγ during mating. In such a mechanism, it would not be necessary to inhibit or erase the incipient bud site during mating as previously suggested ([@B25]). It is, however, possible that the binding of Cdc24p to Far1p results not only in an increased level of interaction with Gβγ but also a decrease in the amount of Cdc24p at the bud site, perhaps by decreasing its affinity for Bud1-GTP. We favor the notion of a balance between Cdc24p activation at the new bud site and at the region of the plasma membrane adjacent to pheromone source. We propose that Far1p serves to bias this equilibrium, i.e., shift the balance, towards the site for shmoo formation.

Cells from a variety of organisms undergo polarized growth in response to external signals. For example, in *C*. *elegans* embryonic development it is the sperm entry site that determines antero-posterior axis ([@B30]). In *Dictyostelium*, cell aggregation occurs via cAMP-mediated chemotaxis ([@B51]) and local activation of G-protein signaling events occurs in the absence of cell movement ([@B50]). Chemotaxis is necessary for cell migration responses for example of lymphocytes ([@B2]). Chemotropism is also essential for axonal guidance and neuronal growth cone remodeling and extension ([@B69]). Such processes are crucial for tissue and organ development. Many of these chemotactic and chemotropic processes appear similar to chemotropism during yeast mating, in that they depend on chemoattractant gradients that are recognized and transmitted by a molecular machinery including G-protein coupled receptors, rho-family GTPases, and their exchange factors. Chemotropic growth in yeast is therefore a suitable model for understanding the molecular basis of many different chemotropic and chemotactic processes.
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:   green fluorescent protein

GST

:   glutathione-*S*-transferase

HA

:   hemagglutinin

MAP

:   mitogen-activated protein

MBP

:   maltose binding protein

TPI

:   triose phosphate isomerase

TEV

:   tobacco etch virus

We have now demonstrated that in the absence of *CDC24*-mediated chemotropism, in addition to Bud1p, other components of the general bud site selection machinery are important for shmoo formation (Nern, A., and R.A. Arkowitz, manuscript submitted for publication).

###### 

Yeast Strains Used in This Study

  Strain                                            Genotype                                                                                  Source
  ---------------------------------------------- -- -------------------------------------------------------------------------------------- -- --------------------------
  K699                                              *Mat**a**, ura3, leu2-3,-112, trp1-1, ade2-1, can1-100, his3-11,-15, ssd1-Δ2, GAL*        K. Nasmyth (IMP, Vienna)
  PJ69-4A                                           *Mat**a**, trp1-901, leu2-3,-112, ura3-52, his3-200, gal4Δ, gal80Δ, GAL2-ADE2,*           [@B35]
                                                      *LYS2::GAL1-HIS3, met2::GAL7-lacZ*                                                      
  SEY6210                                           *Matα, leu2-3,-112, ura3-52, his3-Δ200, trp1-Δ901, lys2-801, suc2-Δ9*                     S. Emr (University of
                                                                                                                                               California, San Diego)
  SEY6211                                           *Mat**a**, leu2-3,-112, ura3-52, his3-Δ200, trp1-Δ901, ade2, suc2-Δ9*                     S. Emr
  SFY526                                            *Mat**a**, gal4, gal80, his3-200, trp1-901 ade2-101, lys2-801, ura3-52,*                  Clontech
                                                      *leu2-3,-112, URA3::pGal1-lacZ, can^r^*                                                 
  Y187                                              *MATα, gal4, gal80, his3, trp1-901, ade2-101, ura3-52, leu2-3,-112, URA3::pGal-lacZ*      Clontech
  RAY719                                            Same as SEY6210 with *bem1Δ-1::HIS3*                                                      [@B3]
  RAY899                                            Same as SEY6210 with *ste20::LoxP HIS5Sp LoxP*                                            This study
  RAY910                                            Same as SEY6211 with *ste4::HASTE4*                                                       This study
  RAY912                                            Same as SEY6211 with *ste4::HASTE4 cdc24::TRP1 3xmyc CDC24*                               This study
  RAY931                                            Same as SEY6211 with *cdc24Δ-1::LoxP HIS5Sp LoxP* and pEG(KT)CDC24                        [@B49]
  RAY1034                                           Same as SEY6211 with *cdc24::TRP1 CDC24*                                                  [@B49]
  RAY1035                                           Same as SEY6211 with *cdc24::TRP1 cdc24-m1*                                               [@B49]
  RAY1036                                           Same as PJ69-4A with *ste7Δ-1::URA3Kl*                                                    This study
  RAY1041                                           Same as SEY6210 with *cdc24::TRP1 CDC24*                                                  [@B49]
  RAY1072                                           Same as PJ69-4A with *ste4Δ-1::URA3Kl*                                                    This study
  RAY1074                                           Same as PJ69-4A with *ste5Δ-1::URA3Kl*                                                    This study
  RAY1086                                           Same as PJ69-4A with *akr1Δ-1::URA3Kl*                                                    This study
  RAY1109                                           Same as RAY1034 with *far1Δ-1::URA3Kl*                                                    This study
  RAY1111                                           Same as RAY1035 with *far1Δ-1::URA3Kl*                                                    This study
  RAY1113                                           Same as PJ69-4A with *far1Δ-2::URA3Kl*                                                    This study
  RAY1114                                           Same as PJ69-4A with *ste20Δ-1::URA3Kl*                                                   This study
  RAY1121                                           Same as PJ69-4A with *kss1Δ-1::URA3Kl*                                                    This study
  RAY1123                                           Same as PJ69-4A with *ste11Δ-1::URA3Kl*                                                   This study
  RAY1135[\*](#TFI-150){ref-type="table-fn"}        Same as SEY6210 except *LEU2*                                                             This study
  RAY1139[‡](#TFI-152){ref-type="table-fn"}         Same as RAY1034 with *bud1Δ-1::LoxP HIS5Sp LoxP*                                          This study
  RAY1142[‡](#TFI-152){ref-type="table-fn"}         Same as RAY1035 with *bud1Δ-1::LoxP HIS5Sp LoxP*                                          This study
  RAY1160[§](#TFI-153){ref-type="table-fn"}         Same as RAY1035 with *ste20Δ-1::LoxP HIS5Sp LoxP*                                         This study
  RAY1168[‖](#TFI-155){ref-type="table-fn"}         Same as RAY1035 with *bem1Δ-1::HIS3*                                                      This study
  RAY1173 [¶](#TFI-154){ref-type="table-fn"}        Same as RAY1034 with *bem1Δ-1::HIS3*                                                      This study
  RAY1179                                           Same as PJ69-4A with *fus3Δ-1::URA3Kl*                                                    This study
  RAY1182                                           Same as Y187 with *far1-H7::LoxP HIS5Sp LoxP*                                             This study
  RAY1183                                           Same as Y187 with *far1Δ-1::LoxP HIS5Sp LoxP*                                             This study
  RAY1246                                           Same as RAY1034 with *spa2Δ-1::LoxP HIS5Sp LoxP*                                          This study
  RAY1248                                           Same as RAY1035 with *spa2Δ-1::LoxP HIS5Sp LoxP*                                          This study
  RAY1249                                           Same as RAY1034 with *far1Δ-1::URA3Kl, bud1Δ-1::LoxP HIS5Sp LoxP*                         This study
  RAY1254                                           Same as K699 with *cdc24::TRP1 3xmyc CDC24*                                               This study
  RAY1258                                           Same as K699 with *cdc24::TRP1 3xmyc CDC24, far1::FAR1 ProtA HIS5Sp*                      This study
  RAY1260                                           Same as K699 with *cdc24::TRP1 3xmyc CDC24-m1, far1::FAR1 ProtA HIS5Sp*                   This study
  RAY1271[\*\*](#TFI-160){ref-type="table-fn"}      Same as RAY1034 with *ste20Δ-1::LoxP HIS5Sp LoxP*                                         This study
  RAY1276                                           Same as SEY6211 with *ste4::HASTE4 ProtA HIS5Sp, cdc24::TRP1 3xmyc CDC24*                 This study
  RAY1336                                           Same as K699 with *cdc24::TRP1 3xmyc cdc24, far1::far1-H7 ProtA HIS5Sp*                   This study
  RAY1342[‡](#TFI-152){ref-type="table-fn"}         Same as RAY1034 with *sst2Δ-1::URA3Kl*                                                    This study
  RAY1350[‡](#TFI-152){ref-type="table-fn"}         Same as RAY1034 with *sst2Δ-1::URA3Kl, bud1Δ-1::LoxP HIS5Sp LoxP*                         This study
  RAY1360                                           Same as RAY931 with p414Cdc24HAGFP instead of pEG(KT)CDC24                                This study
  RAY1449                                           Same as PJ69-4A with *cdc24::TRP1 cdc24-m1*                                               This study

*HIS5Sp* refers to *HIS5* from *S. pombe* and *URA3Kl* refers to *URA3* from *K. lactis*.  

 Transformed with *LEU2* fragment to make *LEU2* ^+^.  

 Strains made by deletion in a haploid, crossing with appropriate haploid followed by sporulation.  

 Made by crossing RAY1035 with RAY899 followed by sporulation.  

 Made by crossing RAY1035 with RAY719 followed by sporulation.  

 Made by crossing RAY1034 with RAY719 followed by sporulation.  

Made by crossing RAY1034 with RAY899 followed by sporulation.  

![Two-hybrid interaction between Cdc24p and Gβ requires Gγ and Far1p. (A) Overexpression of Gγ and Far1p enhances the Cdc24p--Gβ interaction. Assays were carried out in a Y187 strain grown in SC-leu-trp-ade or SC-leu-trp-ade-his. LacZ values are the average of three to five determinations with bars showing standard deviation. As indicated, *SPA2* (NH~2~-terminal 153 amino acids), *CDC24*, *STE4*, *STE18*, or *FAR1* (entire ORF) were fused either to *GAL4* activation domain (AD) or *GAL4* DNA binding domain (DBD). Spa2 serves as a DBDCdc24 negative control and Cdc24-m1 serves as an ADSte4 negative control. For overexpression, NLSHA-STE18 and NLSHA-FAR1 in plasmids p2μATPI and p413TPI were used. (B) Optimal interaction between Cdc24p and Gβ in a diploid requires Gγ and Far1p. Assays were carried out in a diploid strain made by crossing SFY526 and Y187 as described above. (C) Cdc24p--Gβ interaction requires *FAR1* orientation function. Assays were carried out in a Y187 strain in which *FAR1* was either deleted (RAY1183) or replaced by *far1-H7* (RAY1182).](JCB9811053.f1){#F1}

###### 

Requirements of Cdc24p Ste4p Interaction

  Strain                                           Cdc24p Ste4p interaction      +Ste18p
  --------------------------------------------- -- -------------------------- -- ---------
  *Δste4*                                          ++                            ND
  *Δste18*                                         \-                            ++
  *Δste5*                                          \-                            \+
  *Δste20*                                         \-                            ±
  *Δste11*                                         \-                            \+
  *Δste7*                                          \-                            \+
  *Δkss1*                                          ++                            ND
  *Δfus3*                                          ++                            ND
  *Δste12*                                         \-                            ±
  *Δfar1*                                          \-                            \-
  *Δbem1[\*](#TFII-150){ref-type="table-fn"}*      ++                            ND
  *Δakr1*                                          ++                            ND
  *Δbud6*                                          ++                            ND
  *Δskm1*                                          ++                            ND

Two-hybrid assays were carried out in strain PJ69-4A with the indicated gene deletions. Identical results were obtained with at least three transformants. ++ Denotes clear growth on selective plates lacking histidine.  

 Plates incubated at 25°C.  

###### 

Far1p Interacts with Cdc24p and Ste4p

  Strain          Far1 Cdc24 interaction      Far1 Ste4 interaction
  ------------ -- ------------------------ -- -----------------------
  Wild-type       ++                          ++
  *Δste4*         ++                          ++
  *Δste18*        ++                          ++
  *Δfus3*         ++                          ++
  *Δste12*        ++                          ++
  *cdc24-m1*      N[Δ]{.smallcaps}            ++

Two-hybrid assays were carried out in strain PJ69-4A with the indicated gene replacements. Identical results were obtained with at least three transformants. ++ Denotes growth on SC-leu-trp-his or in the case of *cdc24-m1* SC-leu-ura-his.  

![Cdc24p specifically binds Far1p in vivo. Extracts from strains (lanes 1 and 2 RAY1254; lanes 3 and 4 RAY1258; lanes 5 and 6 RAY1260; lanes 7 and 8 RAY1336) with an activated pheromone response carrying Far1-protein A (lanes 3--6), Far1-H7-protein A (lanes 7 and 8), 3xmycCdc24 (lanes 1--4 and 7 and 8), and 3xmycCdc24-m1 (lanes 5 and 6) were incubated with IgG-Sepharose and bound proteins analyzed by 10% SDS-PAGE. Upper panel was probed with anti-myc, lower panel with anti-Far1p serum. Bacterially expressed MBPFar1 was added to the sample in lane 1.](JCB9811053.f2){#F2}

![Cdc24p directly binds Far1p. (A) MBPFar1 (0.3 μM, lanes 3 and 5) or MBPFar1-H7 (0.3 μM, lanes 4 and 6) was incubated the NH~2~-terminal half of Cdc24 fused to GST denoted GSTCdc24 (1 μM, lanes 3 and 4) or GST (3 μM, lanes 5 and 6) bound to glutathione-agarose. Bound proteins were analyzed by 10% SDS-PAGE, and Coomassie blue staining. Lanes 1 and 2 show standards representing 5% of added MBPFar1 or MBPFar1-H7. Bands at ∼97 kD are breakdown products of MBPFar1 and MBPFar1-H7 that reacted with anti-MBP mAb hence lack the COOH termini. While full-length MBPFar1 was substantially enriched over this MBPFar1 fragment in GSTCdc24 pulldowns, these breakdown products were still observed in resin eluates consistent with MBPFar1 oligomerization. (B) Concentration dependence of MBPFar1 binding to GSTCdc24. MBPFar1-H7 (lanes 3, 4, and 5) and MBPFar1 (lanes 6, 7, and 8) at concentrations 75 nM (lanes 3 and 6), 150 nM (lanes 4 and 7), and 300 nM (lanes 5 and 8) was added to 1 μM GSTCdc24 bound to glutathione-agarose. Samples were analyzed as described above. Lanes 1 and 2 show standards representing 20% (for lanes 3 and 6), 10% (for lanes 4 and 7), and 5% (for lanes 5 and 8) of added MBPFar1 or MBPFar1-H7.](JCB9811053.f3){#F3}

###### 

Delineation of Far1p region necessary for Cdc24p and Gβ binding. (A) Far1p fragments. Far1 fragments contained amino acid residues 133--831 for Far1, residues 133--756 for Far1-H7, residues 133--297 for Far1ΔC, residues 638--831 for Far1ΔN, and residues 638--756 for Far1-H7ΔN fused to MBP. (B) The Far1p COOH terminus is necessary for Cdc24p binding. GSTCdc24 (0.9 μM) bound to glutathione-agarose was incubated with MBP fusions (∼0.5 μM) as indicated. Samples were analyzed by 10% SDS-PAGE, followed by immunoblotting with anti-MBP mAb and ECL. Lanes 1--6 show standards representing 5% of added MBP fusions and lanes 7--12 show resin eluates. GST alone did not bind any MBP fusions. (C) The NH~2~ terminus of Far1p is necessary for binding yeast Gβ. Indicated MBP fusions bound to amylose resin were incubated with yeast HASte4p purified from RAY1276. Samples were prepared and analyzed as described above by 10% SDS-PAGE using anti-HA mAb. Anti-MBP immunoblots revealed lanes 4--7 had similar amounts of MBP fusions whereas lanes 2 and 3 had approximately two- to threefold less MBP fusion. Lanes 1 and 8 show standard representing 12.5% and 6.2% of added HASte4p, respectively.

![](JCB9811053.f4bc)

![](JCB9811053.f4a)

![Cdc24p, Far1p, and Gβ form a trimeric complex. (A) Cdc24p binds Gβ in the presence of MBPFar1. GSTCdc24 (0.7 μM) bound to glutathione-agarose was incubated with yeast HASte4p and 0.5 μM MBPFar1 or 7.4 μM MBP as indicated. Samples prepared and analyzed by 10% SDS-PAGE as described in Fig. [4](#F4){ref-type="fig"} C (α-HA) or analyzed by Coomassie blue staining. For the α-HA blot 10% of added HASte4p was used as a standard. GST alone did not bind HASte4p. (B) A trimeric Cdc24p-Far1p-Gβ complex. GSTCdc24-MBPFar1 was prepared and ∼10% of this complex was analyzed by SDS-PAGE and Coomassie blue staining. Approximately 30% GSTCdc24-MBPFar1 or GSTCdc24 alone was incubated with yeast HASte4p. Samples were prepared and analyzed as described above using anti-HA mAb (α-HA) or anti-MBP mAb (α-MBP). For the α-HA blot 2.5% of added HASte4p was used as a standard.](JCB9811053.f5){#F5}

![*CDC24* and *FAR1* function in same shmoo orientation pathway. Quantitative matings were carried out with a wild-type tester (RAY1135) and mating efficiencies (number of diploid cells divided by total number of cells) are the average of three to five determinations with wild-type mating efficiency (42%) set to 100%. Strains RAY1034, RAY1035, RAY1109, RAY1111, RAY1246, RAY1248, RAY1271, RAY1160, RAY1173, and RAY1168 were used. Bars indicate standard deviation.](JCB9811053.f6){#F6}

![Cdc24p localizes to sites of polarized growth. (A) Cdc24p localizes to sites of polarized growth in budding cells. Confocal micrographs of live *Δcdc24* p414Cdc24HAGFP cells (RAY1360) at different stages in the cell cycle. At each stage in the cell cycle background fluorescence was observed in the cytosol that varied from cell to cell. (B) Cdc24p localizes to the shmoo tip. Cells treated with 140 μM α-factor for 1 h were imaged as described above. Bar, 5 μm.](JCB9811053.f7){#F7}

![Cdc24p localization requires the actin cytoskeleton in shmoos but not budding cells. (A) Cdc24p localization in budding cells does not require the actin cytoskeleton. *ΔCdc24* p414Cdc24HAGFP cells (RAY1360) were treated with either 0.1 mM latrunculin A or DMSO for 3 h. Cdc24HAGFP was detected as described in Fig. [7](#F7){ref-type="fig"} A. Cells were also fixed and stained with rhodamine phalloidin to visualize actin cytoskeleton. (B) Cdc24p localization in shmoos requires the actin cytoskeleton. RAY1360 cells were treated with 140 μM α-factor for 1 h and then either 0.1 mM latrunculin A or DMSO was added for 2 h. Cdc24HAGFP and actin cytoskeleton were visualized as described above. Note the upper cell in Cdc24 panel treated with DMSO is initiating a second mating projection where Cdc24HAGFP is observed. Fluorescent material within cells in Cdc24 panels is attributed to fluorescence due to *ade2*. Bar, 5 μm.](JCB9811053.f8){#F8}

![In the absence of chemotropic signaling *BUD1* functions in mating. (A) Combination of *Δbud1* with either *cdc24-m1* or *Δfar1* results in a synthetic mating defect. Quantitative mating carried out as described in Fig. [6](#F6){ref-type="fig"}. Strains RAY1034, RAY1139, RAY1035, RAY1142, RAY1109, RAY1249, RAY1342, and RAY1350 were used. (B) *BUD1* is necessary for shmoo formation in pheromone treated *cdc24-m1* cells. DIC images of α-factor treated (12 μM for 3 h) cells (genotype indicated). (C) *BUD1* is necessary for shmoo formation in mating mixtures. Cells with genotype indicated stained with Calcofluor white, mated with a wild-type. Fluorescence and DIC images were merged. (D) Actin cytoskeleton is depolarized in *cdc24-m1 Δbud1* cells treated with α-factor. Cells with genotype indicated were treated with α-factor and actin cytoskeleton visualized as described in Fig. [7](#F7){ref-type="fig"} D. Bars, 5 μm.](JCB9811053.f9){#F9}

![Model of Cdc24p signaling in growth orientation. Empty rings represent bud scars. Cdc24p is localized to the bud site during vegetative growth and upon exposure to a mating pheromone gradient associates with Far1p and Gβγ that is released by receptor activation (not shown). The dashed line between Cdc24p at the bud site and the site for oriented growth during mating indicates that Cdc24p can switch between these two locations. Presumably Bud1p is involved in signaling to Cdc24p at the bud site. It is assumed that signaling to Cdc24p during mating and budding regulates Cdc42p which is necessary for appropriate orientation of the actin cytoskeleton.](JCB9811053.f10){#F10}
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